Jane Street
VKTX icon

Jane Street’s Viking Therapeutics VKTX Stock Holding History

Jane Street’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.2M Sell
252,100
-383,900
-60% -$12.3M ﹤0.01% 2791
2025
Q4 		$22.4M Sell
636,000
-69,500
-10% -$2.46M ﹤0.01% 1523
2025
Q3 		$18.5M Buy
705,500
+199,200
+39% +$5.94M ﹤0.01% 1735
2025
Q2 		$13.4M Sell
506,300
-216,900
-30% -$5.71M ﹤0.01% 1826
2025
Q1 		$17.5M Buy
723,200
+129,500
+22% +$4.09M ﹤0.01% 1411
2024
Q4 		$23.9M Buy
593,700
+114,900
+24% +$6.55M 0.01% 1141
2024
Q3 		$30.3M Sell
478,800
-261,300
-35% -$15.3M 0.01% 972
2024
Q2 		$39.2M Buy
740,100
+107,600
+17% +$7.05M 0.01% 836
2024
Q1 		$51.9M Buy
632,500
+534,200
+543% +$23.8M 0.01% 611
2023
Q4 		$1.83M Sell
98,300
-33,300
-25% -$436K ﹤0.01% 4482
2023
Q3 		$1.46M Sell
131,600
-1,052,900
-89% -$15.1M ﹤0.01% 4572
2023
Q2 		$19.2M Sell
1,184,500
-84,600
-7% -$1.77M 0.01% 1250
2023
Q1 		$21.1M Buy
1,269,100
+1,130,500
+816% +$11.7M 0.01% 966
2022
Q4 		$1.3M Buy
+138,600
New +$619K ﹤0.01% 4551
2022
Q1 		– Sell
-47,200
Closed -$217K – 11082
2021
Q4 		$217K Sell
47,200
-37,200
-44% -$208K ﹤0.01% 8701
2021
Q3 		$530K Sell
84,400
-20,600
-20% -$127K ﹤0.01% 7176
2021
Q2 		$629K Sell
105,000
-9,300
-8% -$55.2K ﹤0.01% 6812
2021
Q1 		$723K Buy
114,300
+39,200
+52% +$276K ﹤0.01% 6099
2020
Q4 		$423K Sell
75,100
-87,000
-54% -$527K ﹤0.01% 5970
2020
Q3 		$943K Sell
162,100
-167,800
-51% -$1.16M ﹤0.01% 4191
2020
Q2 		$2.38M Buy
329,900
+315,200
+2,144% +$2.09M ﹤0.01% 2812
2020
Q1 		$69K Buy
+14,700
New +$90.4K ﹤0.01% 5040
2019
Q2 		– Sell
-67,700
Closed -$673K – 5793
2019
Q1 		$673K Buy
67,700
+48,300
+249% +$404K ﹤0.01% 3302
2018
Q4 		$148K Buy
19,400
+4,000
+26% +$47.8K ﹤0.01% 4566
2018
Q3 		$268K Buy
+15,400
New +$183K ﹤0.01% 4353

Other funds holding VKTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Jane Street's VKTX Position: Q1 2026 in Review

Jane Street reduced its Viking Therapeutics (VKTX) stake by 50% in Q1 2026, selling an estimated $24.2M and leaving 748,949 shares worth $24.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1612.

Jane Street first reported a position in VKTX in Q3 2018 and has held it in 29 quarters since. The position peaked at $52.8M in Q4 2025. 410 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

  • Jane Street held 748,949 shares of Viking Therapeutics worth $24.4M as of Q1 2026.
  • Jane Street sold 752,168 Viking Therapeutics shares in Q1 2026, an estimated $24.2M.
  • Viking Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #1612 holding.
  • Jane Street first reported a position in Viking Therapeutics in Q3 2018 and has held it in 29 quarters since.
  • Jane Street's Viking Therapeutics position peaked at $52.8M in Q4 2025.
  • 410 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.